You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
INDICATIONS AS AT 6 NOVEMBER 2003: Cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. Gram-negative: H. influenzae, E coli, Pr. mirabilis, and N. gonorrhoeae. Gram-positive: Streptococcus species, S. pneumoniae, non-penicllinase producing Staphlococci and Bacillus anthracis. Note 1: Cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to Cilamox should be performed. Note 2: Penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in Bacillus anthracis. If use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. Amoxycillin may then be suitable if the specific B. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
INDICATIONS AS AT 6 NOVEMBER 2003: Cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. Gram-negative: H. influenzae, E coli, Pr. mirabilis, and N. gonorrhoeae. Gram-positive: Streptococcus species, S. pneumoniae, non-penicllinase producing Staphlococci and Bacillus anthracis. Note 1: Cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to Cilamox should be performed. Note 2: Penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in Bacillus anthracis. If use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. Amoxycillin may then be suitable if the specific B. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
INDICATIONS AS AT 6 NOVEMBER 2003: Cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. Gram-negative: H. influenzae, E coli, Pr. mirabilis, and N. gonorrhoeae. Gram-positive: Streptococcus species, S. pneumoniae, non-penicllinase producing Staphlococci and Bacillus anthracis. Note 1: Cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to Cilamox should be performed. Note 2: Penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in Bacillus anthracis. If use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. Amoxycillin may then be suitable if the specific B. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
INDICATIONS AS AT 6 NOVEMBER 2003: Cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. Gram-negative: H. influenzae, E coli, Pr. mirabilis, and N. gonorrhoeae. Gram-positive: Streptococcus species, S. pneumoniae, non-penicllinase producing Staphlococci and Bacillus anthracis. Note 1: Cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to Cilamox should be performed. Note 2: Penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in Bacillus anthracis. If use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. Amoxycillin may then be suitable if the specific B. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.